Biliary Tract Cancer Clinical Trials in Washington D.C., District of Columbia

3 studies are recruiting for biliary tract cancer in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

    Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or with other treatments can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are either advanced (the cancer has spread to other parts of the body), or unresectable (the cancer cannot be removed with surg…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sibley Memorial Hospital ( Site 0310), Washington D.C., District of Columbia
    Locations
    55 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06428409 on ClinicalTrials.gov

  2. A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

    The purpose of this study is to measure the efficacy and safety of rilvegostomig with gemcitabine plus cisplatin vs. durvalumab with gemcitabine plus cisplatin as first line treatment for patients with advanced BTC.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Washington D.C., District of Columbia
    Locations
    177 in total
    Run by
    AstraZeneca

    See if you can join NCT07221253 on ClinicalTrials.gov

  3. Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

    The purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.

    Stage
    Phase 3
    Ages
    18 to 99
    Site
    Research Site, Washington D.C., District of Columbia
    Locations
    269 in total
    Run by
    AstraZeneca

    See if you can join NCT06467357 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.